KR20130117033A - Ovotrasferrin hydrolysate having with antioxidant activity and method for preparation thereof - Google Patents
Ovotrasferrin hydrolysate having with antioxidant activity and method for preparation thereof Download PDFInfo
- Publication number
- KR20130117033A KR20130117033A KR1020120039672A KR20120039672A KR20130117033A KR 20130117033 A KR20130117033 A KR 20130117033A KR 1020120039672 A KR1020120039672 A KR 1020120039672A KR 20120039672 A KR20120039672 A KR 20120039672A KR 20130117033 A KR20130117033 A KR 20130117033A
- Authority
- KR
- South Korea
- Prior art keywords
- hydrolyzate
- overtransferin
- tcep
- present
- overtransferrin
- Prior art date
Links
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 17
- 238000000034 method Methods 0.000 title claims description 12
- 239000000413 hydrolysate Substances 0.000 title abstract 4
- 238000002360 preparation method Methods 0.000 title description 2
- PBVAJRFEEOIAGW-UHFFFAOYSA-N 3-[bis(2-carboxyethyl)phosphanyl]propanoic acid;hydrochloride Chemical compound Cl.OC(=O)CCP(CCC(O)=O)CCC(O)=O PBVAJRFEEOIAGW-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000006228 supernatant Substances 0.000 claims abstract description 7
- 239000003963 antioxidant agent Substances 0.000 claims description 16
- 230000002401 inhibitory effect Effects 0.000 claims description 8
- 230000003859 lipid peroxidation Effects 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 238000000502 dialysis Methods 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- 239000013589 supplement Substances 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims 1
- 230000008014 freezing Effects 0.000 claims 1
- 238000007710 freezing Methods 0.000 claims 1
- 239000012581 transferrin Substances 0.000 abstract description 8
- 102000004338 Transferrin Human genes 0.000 abstract description 7
- 108090000901 Transferrin Proteins 0.000 abstract description 7
- 238000006460 hydrolysis reaction Methods 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 230000007062 hydrolysis Effects 0.000 abstract description 2
- 235000006708 antioxidants Nutrition 0.000 description 15
- 235000013305 food Nutrition 0.000 description 15
- 238000002835 absorbance Methods 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 235000013361 beverage Nutrition 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 230000003647 oxidation Effects 0.000 description 7
- 238000007254 oxidation reaction Methods 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- SUBFIBLJQMMKBK-UHFFFAOYSA-K iron(3+);trithiocyanate Chemical compound [Fe+3].[S-]C#N.[S-]C#N.[S-]C#N SUBFIBLJQMMKBK-UHFFFAOYSA-K 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 102000002322 Egg Proteins Human genes 0.000 description 4
- 108010000912 Egg Proteins Proteins 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000013355 food flavoring agent Nutrition 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 150000002978 peroxides Chemical class 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 3
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 3
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 235000013601 eggs Nutrition 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- NMCUIPGRVMDVDB-UHFFFAOYSA-L iron dichloride Chemical compound Cl[Fe]Cl NMCUIPGRVMDVDB-UHFFFAOYSA-L 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- SOIFLUNRINLCBN-UHFFFAOYSA-N ammonium thiocyanate Chemical compound [NH4+].[S-]C#N SOIFLUNRINLCBN-UHFFFAOYSA-N 0.000 description 2
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 2
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 238000006388 chemical passivation reaction Methods 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 235000014103 egg white Nutrition 0.000 description 2
- 210000000969 egg white Anatomy 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229960002089 ferrous chloride Drugs 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- -1 iron ions Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- GHCZTIFQWKKGSB-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O GHCZTIFQWKKGSB-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 102000008133 Iron-Binding Proteins Human genes 0.000 description 1
- 108010035210 Iron-Binding Proteins Proteins 0.000 description 1
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 150000001728 carbonyl compounds Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000002434 immunopotentiative effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 231100000378 teratogenic Toxicity 0.000 description 1
- 230000003390 teratogenic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- POSZUTFLHGNLHX-KSBRXOFISA-N tris maleate Chemical compound OCC(N)(CO)CO.OCC(N)(CO)CO.OC(=O)\C=C/C(O)=O POSZUTFLHGNLHX-KSBRXOFISA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 235000020795 whole food diet Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
- A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/54—Proteins
- A23V2250/542—Animal Protein
- A23V2250/5428—Egg protein
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/54—Proteins
- A23V2250/55—Peptide, protein hydrolysate
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
본 발명은 오버트랜스페린이 포함하고 있는 15개의 이황화 결합 부위를 선택적으로 절단하는 Tris(2-carboxyethyl) phosphine hydrochloride (TCEP)를 통해서 상기 오버트랜스페린의 이황화 결합을 절단하여 기능성 오버트랜스페린 가수분해물을 제조하고 그 가수분해물을 유효성분으로 하는 항산화 소재개발에 관한 것이다.The present invention provides a functional overtransferrin hydrolyzate by cleaving the disulfide bond of the overtransferin through Tris (2-carboxyethyl) phosphine hydrochloride (TCEP) that selectively cleaves 15 disulfide bond sites contained in the overtransferrin. It relates to the development of an antioxidant material using the hydrolyzate as an active ingredient.
항산화란 물질의 산화를 억제하는 성질로 식품계에서는 산화에 의해 일어나는 식품의 풍미와 색의 변화, 유지의 산패 등을 방지하거나 지연하는 기능을 말한다. 상기의 산화를 억제하는 기능은 식품계 뿐만 아니라 생체 내에서도 활성산소로 인해 발생하는 암이나, 동맥경화, 당뇨병과 같은 질병을 예방할 수 있어 항산화제에 대한 관심이 고조되고 있다(손 등, 식품과학과 산업, 30:22-29, 1997). Antioxidant is a property of inhibiting the oxidation of a substance, and in the food industry, it is a function of preventing or delaying changes in flavor and color of food caused by oxidation and rancidity of fats and oils. The antioxidant function prevents diseases such as cancer, arteriosclerosis, and diabetes caused by free radicals not only in the food system but also in the living body, and thus, there is a growing interest in antioxidants (hands, food science and industry). , 30: 22-29, 1997).
일반적으로 현재 사용하고 있는 항산화제는 합성 항산화제와 천연 항산화제로 구분되는데, 대표적인 합성 항산화제인 butylated hydroxytoluene (BHT)은 동물실험에서 기형 발생 또는 암 발생에 관여하는 것으로 보고되고 있어(Branen et al., Amer. Oil Chem. Soc., 52;59-63, 1975) 뛰어난 항산화 효과에 반해 그로 인한 부작용 역시 문제시되고 있다. 반면 천연 항산화제는 합성 항산화제와 비교했을 때 부작용이 거의 없어 식품첨가물 또는 약품으로 현재 α-tocopherol이 사용되고 있지만, 비싼 가격과 지용성이라는 이용 상의 제약으로 인해 대체 천연 항산화제의 개발이 요구되고 있는 실정이기에 이에 관한 연구가 활발히 이루어지고 있다(Lee et al., Korean J. Food Preserv., 11;126-129, 2004, Lee et al., J. Life Sci., 18;1106-1114, 2008).
Generally, the antioxidants currently used are classified into synthetic antioxidants and natural antioxidants. A representative synthetic antioxidant, butylated hydroxytoluene (BHT), has been reported to be involved in teratogenic or cancerous development in animal experiments (Branen et al., Amer.Oil Chem. Soc., 52; 59-63, 1975) While its superior antioxidant effects, side effects are also problematic. On the other hand, natural antioxidants have almost no side effects compared to synthetic antioxidants, but α-tocopherol is currently used as a food additive or drug, but due to the constraints of high price and fat solubility, development of alternative natural antioxidants is required. This research is being actively conducted (Lee et al., Korean J. Food Preserv., 11; 126-129, 2004, Lee et al., J. Life Sci., 18; 1106-1114, 2008).
천연의 완전식품으로 잘 알려진 계란은 각 성분들의 생리적 기능과 상호작용에 의한 역할이 밝혀지고 있고, 기능성 건강식품의 주요한 소재로 사용될 수 있다는 점에서 그 중요성이 더욱 강조되고 있다(Jeon et al., J. Food Sci. Ani. Resour.,22;267-273, 2002). 달걀의 철 결합 단백질인 오버트랜스페린은 albumin 다음으로 많은 비중을 차지하는 단일체 당단백질로서 한 분자 당 15개의 이황화 결합을 갖고 있으며, 2개의 철 이온과 결합할 수 있는 능력을 지닌 transferrin의 일종이다 (Wu and Acero-Lopez, Food Res. Int., 46;480-487, 2012). 이와 같이 철 원자에 대한 높은 결합력을 가져 미생물 성장에 필수 영양 성분인 철을 결합하여 제거함으로써 항균력을 가지는 것으로 알려져 있고(Ibrahim. et al., Bioch. Biophys. Acta., 1523;196-205, 2000) 그 외에도 항암(Ibrahim and Kiyono, J. Agric. Chem. 57;11383-11390, 2009), 면역증강(Hirota et al., J. Vet. Med. Sci., 57;825-829, 1995), 항 고혈압(Lee et al., J. Food Sci. Ani. Resour., 30;286-290, 2010) 등의 생리활성이 알려져 있다.
Eggs, which are well known as natural whole foods, have been found to play a role in the physiological functions and interactions of each ingredient, and their importance is further emphasized in that they can be used as the main ingredients of functional health foods (Jeon et al., J. Food Sci.Ani.Resour., 22; 267-273, 2002). Overtransferrin, the iron-binding protein of eggs, is the second most common monosaccharide glycoprotein after albumin, with 15 disulfide bonds per molecule and a type of transferrin capable of binding two iron ions (Wu and Acero-Lopez, Food Res. Int., 46; 480-487, 2012). As such, it has been known to have an antimicrobial activity by binding to iron, which is an essential nutrient for microbial growth, by having a high binding force to iron atoms (Ibrahim. Et al., Bioch. Biophys. Acta., 1523; 196-205, 2000 ) In addition, anticancer (Ibrahim and Kiyono, J. Agric. Chem. 57; 11383-11390, 2009), immunopotentiation (Hirota et al., J. Vet. Med. Sci., 57; 825-829, 1995), Antihypertension (Lee et al., J. Food Sci. Ani. Resour., 30; 286-290, 2010) is known.
식품 단백질은 인체 내에서 소화 혹은 식품 제조 과정 중의 발효, 숙성 과정 중 변성을 일으키고 이는 생체 내에서 다양한 생리활성을 나타낼 수 있다고 알려져 있다(Moller et al., 2008). 따라서 단백질뿐만 화학적 물리적 변성이 일어난 단백질 역시도 기능성 소재로서의 가치가 인정된다.
Food proteins are known to cause degeneration during digestion or fermentation and ripening processes in the human body, which can exhibit various biological activities in vivo (Moller et al., 2008). Therefore, proteins as well as proteins with chemical and physical denaturation are recognized as valuable materials.
난백 단백질의 물리, 화학적 변성을 통한 기능성 소재개발에 대해서 대한민국 공개특허 제 10-2011-40018에서는 난백에 존재하는 단백질 오버트랜스페린 가수분해 물의 혈압을 낮추는 활성에 대해 개시하였고, 대한민국 공개특허 제 10-2004-48650호에서는 난백 단백질의 가수 분해물을 함유한 조미료 제조방법에 대해 개시하였다. 또 대한민국 공개특허 제 10-2002-67203호에서는 계란 알끈으로부터 분리한 혈전용해 펩타이드 제조 방법에 대해서 개시하였다.
Korean Patent Application Publication No. 10-2011-40018 discloses an activity for lowering blood pressure of protein overtransferin hydrolyzate present in egg white, and the Republic of Korea Patent Publication No. 10-2004 -48650 discloses a seasoning method containing hydrolyzate of egg white protein. In addition, the Republic of Korea Patent Publication No. 10-2002-67203 discloses a method for producing a thrombolytic peptide isolated from egg string.
따라서, 본 발명의 목적은 난백 단백질인 오버트랜스페린을 TECP를 이용한 가수분해 반응을 통하여 유용한 가수분해물을 유도하는 데 있다.Accordingly, it is an object of the present invention to induce useful hydrolysates of the egg white protein, overtransferin, through a hydrolysis reaction using TECP.
본 발명의 다른 목적은, 상기의 항산화 기능이 증대된 기능성 오버트랜스페린 가수분해물을 제공하는 데 있다. Another object of the present invention is to provide a functional overtransferin hydrolyzate having an enhanced antioxidant function.
본 발명의 상기 목적은 순도가 높은 오버트랜스페린(순도: 98%)에 Tris(2-carboxyethyl)phosphine hydrochloride (TCEP)를 처리하여 오버트랜스페린을 가수분해하는 단계와; 상기 가수분해물을 투석막으로 투석하여 TCEP를 제거하는 단계와; 상기 TCEP가 제거된 오버트랜스페린 가수분해물을 원심분리하여 상층액을 얻고 그 상층액을 동결 건조하는 단계와; 상기 동결건조 시료의 지질과산화 억제 활성을 측정하는 단계를 통하여 달성하였다.The object of the present invention is to hydrolyze the overtransferrin by treating Tris (2-carboxyethyl) phosphine hydrochloride (TCEP) with high-purity overtransferrin (purity: 98%); Dialysis of the hydrolyzate with a dialysis membrane to remove TCEP; Centrifuging the TCEP-removed over-transferrin hydrolyzate to obtain a supernatant, and lyophilizing the supernatant; It was achieved through the step of measuring the lipid peroxidation inhibitory activity of the lyophilized sample.
본 발명은 난백 단백질인 오버트랜스페린을 TECP를 이용한 가수분해 반응을 통하여 가수분해물을 획득하고, 상기 항산화 기능이 증대된 오버트랜스페린의 가수분해물을 제공하는 효과가 있다. The present invention has an effect of obtaining a hydrolyzate of the overtransferin, which is an egg white protein, through a hydrolysis reaction using TECP, and providing a hydrolyzate of the overtransferrin having enhanced antioxidant function.
도 1은 오버트랜스페린를 Tris(2-carboxyethyl)phosphine hydrochloride (TCEP)이용한 가수분해물 제조를 위한 모식도이다.
도 2는 본 발명 TCEP를 통하여 가수분해된 오버트랜스페린의 TBA 실험법을 이용한 지질 과산화 억제활성에 관한 그래프이다; 대조구 (◆),오버트랜스페린 2 mg/mL (▲), 본 발명 가수분해된 ovotrasferrin 2 mg/mL (●), 본 발명 가수분해된 ovotrasferrin 1 mg/mL (△), 본 발명 가수분해된 ovotrasferrin 0.5 mg/mL (○).
도 3은 본 발명 TCEP를 통하여 가수분해된 오버트랜스페린의 FTC 실험법을 이용한 지질 과산화 억제활성에 관한 그래프이다; (◆),오버트랜스페린 2 mg/mL (▲), 본 발명 가수분해된 ovotrasferrin 2 mg/mL (●), 본 발명 가수분해된 ovotrasferrin 1 mg/mL (△), 본 발명 가수분해된 ovotrasferrin 0.5 mg/mL (○). 1 is a schematic diagram for the production of hydrolyzate using overtransferin Tris (2-carboxyethyl) phosphine hydrochloride (TCEP).
Figure 2 is a graph of the lipid peroxidation inhibitory activity using the TBA test of the overtransferin hydrolyzed via TCEP of the present invention; Control (◆),
Figure 3 using the FTC method of the overtransferin hydrolyzed via the present invention TCEP Graph of lipid peroxidation inhibitory activity; (◆),
본 발명에서는 Tris(2-carboxyethyl)phosphine Hydrochloride (TCEP)을 이용해서 순수한 오버트랜스페린 단백질을 가수분해하여 항산화 활성이 우수한 기능성 펩타이드를 개발하고자 하였다.In the present invention, tris (2-carboxyethyl) phosphine Hydrochloride (TCEP) was used to hydrolyze pure overtransferin protein to develop a functional peptide with excellent antioxidant activity.
본 발명 오바트랜스페린 가수분해물은 식품조성물 첨가하여 사용할 수 있다. 상기 본 발명 오바트랜스페린 가수분해물은 5 내지 20 % 의 농축액의 형태 또는 분말형태로 식품조성물에 첨가하는 것이 바람직하다.The obat transferrin hydrolyzate of the present invention can be used by adding a food composition. It is preferable that the present invention ovatransferrin hydrolyzate is added to the food composition in the form of powder or powder form of 5 to 20%.
본 발명 오바트랜스페린 가수분해물을 첨가하여 사용할 수 있는 기능성 식품 조성물은 건강을 위한 식품, 음료, 또는 음료첨가제 등이며, 상기 기능성 조성물은 식품 100 중량%에 대하여 0.1 중량% 내지 20 중량%로 물에 혼합하여 항산화 효과를 목적으로 한 기능성 음료 또는 상기 본 발명 오바트랜스페린 가수분해물을 건조 분말화하여 충진한 연질 또는 경질 캡슐제의 형태로 이용하는 것이 바람직하다.Functional food composition that can be used by adding the present invention the barat transferrin hydrolyzate is a food, beverage, or beverage additives for health, the functional composition is mixed with water in 0.1% to 20% by weight relative to 100% by weight of food It is preferable to use in the form of a soft or hard capsule filled with a functional beverage for the purpose of the antioxidant effect or the powder of the present invention ovatransferrin hydrolyzed to dry powder.
본 발명 오바트랜스페린 가수분해물을 유효성분으로 포함하는 조성물은 항산화 효과를 위한 보조식품 등에도 다양하게 이용될 수 있다. 본 조성물을 첨가할 수 있는 식품으로는, 예를 들어, 각종 식품류, 껌, 캔디, 과자류, 차, 비타민 복합제, 건강기능 식품류 등이 있다.The composition comprising the present invention barat transferrin hydrolyzate as an active ingredient may be used in various ways, such as supplements for the antioxidant effect. Examples of the food to which the present composition can be added include various foods, gums, candy, confectionery, tea, vitamin complexes, and health functional foods.
본 발명 오바트랜스페린 가수분해물이 함유된 음료 조성물은 지시된 비율로 필수 성분으로서 특별한 제한은 없으나 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상기 천연 탄수화물의 예는 모노사카라이드, 예를 들어, 포도당, 과당 등; 디사카라이드, 예를 들어 말토스, 슈크로스, 올리고당 등; 및 폴리사카라이드, 예를 들어 덱스트린, 시클로덱스트린 등과 같은 통상적인 당 및 자일리톨, 소르비톨, 에리트리톨 등의 당알콜이다. 상술한 것 이외의 향미제로서 천연 향미제(타우마틴, 스테비아 추출물(예를 들어 레바우디오시드 A, 글리시르히진 등) 및 합성 향미제(사카린, 아스파르탐 등)를 유리하게 사용할 수 있다.The beverage composition containing the obat transferrin hydrolyzate of the present invention may contain various flavors or natural carbohydrates as additional ingredients, such as ordinary beverages, although there is no particular limitation as an essential ingredient in the indicated ratio. Examples of such natural carbohydrates include monosaccharides such as glucose, fructose, and the like; Disaccharides such as maltose, sucrose, oligosaccharides and the like; And sugars such as conventional sugars such as polysaccharides such as dextrin, cyclodextrin and the like and xylitol, sorbitol, erythritol. As flavoring agents other than those described above, natural flavoring agents (tauumatin, stevia extract (e.g., Rebaudioside A, glycyrrhizin, etc.) and synthetic flavoring agents (saccharin, aspartame, etc.) can be advantageously used. .
상기 외에 본 발명 오바트랜스페린 가수분해물은 여러가지 영양제, 비타민류, 광물(전해질), 식이성분, 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산 음료에 사용되는 탄산화제 등을 함유할 수 있다. 그 밖에 본 발명 오바트랜스페린 가수분해물은 천연 과일 쥬스 및 과일 쥬스 음료 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 본 발명은 요쿠르트 등의 유산균 제제 음료 또는 페이스트 등의 혼합제로 사용할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다. 바람직하게는 본 발명 오바트랜스페린 가수분해물은 100 중량% 당 0.01 내지 약 20 중량부%의 범위에서 선택되는 것이 바람직하다.
In addition to the above, the ovatrantransfer hydrolyzate of the present invention includes various nutrients, vitamins, minerals (electrolytes), dietary ingredients, synthetic flavors and natural flavoring agents, colorants and neutralizing agents (cheese, chocolate, etc.), pectic acid and its Salts, alginic acid and salts thereof, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohols, carbonation agents used in carbonated drinks and the like. In addition, the obat transferrin hydrolyzate of the present invention may contain pulp for producing natural fruit juice and fruit juice beverage and vegetable beverage. The present invention can be used as a mixed agent such as lactic acid bacteria preparation beverages or pastes such as yogurt. These components may be used independently or in combination. Preferably, the inventive obatransferin hydrolyzate is selected from the range of 0.01 to about 20 parts by weight per 100% by weight.
이하, 본 발명의 구체적인 내용을 바람직한 실시예 및 실험예를 통하여 상세히 설명하나, 하기 실시예 및 실험예에 의해 본 발명의 권리 범위가 한정되는 것은 아니다.
Hereinafter, the specific contents of the present invention will be described in detail through preferred examples and experimental examples, but the scope of the present invention is not limited by the following examples and experimental examples.
<< 실시예Example 1> 본 발명 1> invention 오버트랜스페린Overtransferrin 의 가수분해 Hydrolysis of 펩타이드Peptides 제조 Produce
오버트랜스페린(순도: 98%)은 미국의 아이오와주립대학교 (Iowa State University, Ames) 안동욱 교수로부터 제공받아 사용하였다. 상기 오버트랜스페린의 환원을 위해서 사용된 Tris(2-carboxyethyl)phosphine hydrochloride (TCEP) 시약은 Tokyo Chemical Industry Co., Ltd.(Tokyo, Japan)에서 구입하여 사용하였다. Overtransferrin (purity: 98%) was used by Ahn Dong-wook of Iowa State University, Ames. Tris (2-carboxyethyl) phosphine hydrochloride (TCEP) reagent used for the reduction of the overtransferin was purchased from Tokyo Chemical Industry Co., Ltd. (Tokyo, Japan).
오버트랜스페린의 가수분해물은 다음과 같은 방법으로 제조하였다(Ibrahim et al., 2009). 0.2 mM TCEP를 pH 4.0의 20 mM citrate-phosphate buffer에 오버트랜스페린과 함께 녹여 0.1% SDS를 처리하고 37°C에서 6시간 반응시킨 후, 암모늄 수용액을 이용하여 pH를 7.0으로 조절하였다. 이를 cut off size 3,500 Da의 투석막으로 48시간 투석하여 TCEP를 제거해 주었다. 이를 3,000 rpm, 20 분간에서 원심분리(Combi-514R, Hanil, Gyunggi-do, Korea)하여 상층액을 동결 건조하여 실험에 사용하였다.
Hydrolysates of overtransferrin were prepared by the following method (Ibrahim et al., 2009). 0.2 mM TCEP was dissolved in 20 mM citrate-phosphate buffer of pH 4.0 together with overtransferin and treated with 0.1% SDS and reacted at 37 ° C. for 6 hours, and then the pH was adjusted to 7.0 using an aqueous ammonium solution. This was dialyzed for 48 hours with a cut off size of 3,500 Da dialysis membrane to remove TCEP. This was centrifuged at 3,000 rpm for 20 minutes (Combi-514R, Hanil, Gyunggi-do, Korea) and the supernatant was freeze-dried and used in the experiment.
<< 실시예Example 2> 본 발명 2> invention 오버트랜스페린Overtransferrin 가수분해물 Hydrolyzate 의of 항산화능Antioxidant ability 측정 Measure
본 발명 실험예에서 사용한 시약은 ammonium thiocyanate 와 Iron (Ⅱ) chloride tetrahydrate는 Samchun Pure Chemical Co., Ltd. (Gyunggi-do, Korea)에서 구입하였고, ascorbic acd, butylated hydroxyanisole는 Sigma Chemical Co., Ltd. (St. Louis, MO, USA)에서 구입하여 사용하였다.
Ammonium thiocyanate and Iron (II) chloride tetrahydrate were used as Samchun Pure Chemical Co., Ltd. (Gyunggi-do, Korea), and ascorbic acd and butylated hydroxyanisole are manufactured by Sigma Chemical Co., Ltd. Purchased from St. Louis, Mo., USA.
실험예Experimental Example 1 One ThiobarbituricThiobarbituric acidacid (( TBATBA ) 방법에 의한 본 발명 The present invention by the method 오버트랜스페린Overtransferrin 가수분해물 Hydrolyzate 의of 지질과산화 억제 활성 측정 Measurement of Lipid Peroxidation Inhibitory Activity
Thiobarbituric acid를 이용한 지질과산화 측정은 Osawa. et al. (1981)과 Kim et al. (2011)의 방법을 수정하여 측정하였다. Lipid peroxidation using thiobarbituric acid was measured by Osawa. et al. (1981) and Kim et al. (2011) was measured by modifying the method.
Tris-maleate buffer (pH 6.8) 100 mL에 corn oil 1.0 g, Tween 20 0.1 mL 을 첨가하여 균질기(Ika ultra-turrax T25, Staufen, Germany)로 4분간 균질하여 oil emulsion stock 용액을 만들었다. 이 용액 8 mL에 0.2 % ascorbic acid, 200 ppm FeCl3을 각각 0.5 mL씩 넣어주고, 가수분해되지 않은 오버트랜스페린 및 오버트랜스페린의 가수분해물을 농도 별로 1 mL씩 첨가하여 37°C에서 반응하면서 일정 간격으로 흡광도를 측정하였다. 먼저 농도 별 시료 용액 1 mL에 Thiobarbituric acid/trichloroacetic acid(20 mM TBA/15% TCA, w/v) 용액 2 mL, 10% butylated hydroxyanisole solution(10% BHA in 90% ethanol) 50 μL을 첨가하여 90°C에서 15분간 시료가 발색 되도록 하였다. 이를 흐르는 물에 냉각시킨 후 원심분리(3,000 rpm, 15 min)하여 상층액을 532 nm(Optizen 2120 UV plus, Mecasys, Seoul, Korea)에서 흡광도로 측정하였다.
To 100 mL of tris-maleate buffer (pH 6.8), 1.0 g of corn oil and 0.1 mL of
본 발명의 지질의 과산화 정도를 측정하기 위한 알데히드류 측정법의 하나인 TBA 분석법은 다가 불포화지방산의 산화로 2차적으로 생성된 carbonyl compounds 중 대표적인 malonaldehyde와 TBA가 반응한 결과로 나타나는 붉은 색의 정도를 비색 정량하여 유지의 산패 정도를 측정하는 방법이다. TBA analysis, one of the aldehydes measurement methods for measuring the degree of peroxidation of lipids of the present invention, colorizes the red color resulting from the reaction of representative malonaldehyde and TBA among carbonyl compounds secondaryly produced by oxidation of polyunsaturated fatty acids. It is a method to quantify and measure the degree of rancidity of oils and fats.
본 발명에서는 계란 난백에서 추출한 오버트랜스페린 및 본 발명 오버트랜스페린 가수분해물의 성분에 대한 항산화 효과는 oil emulsion 상에서 대조구와 항산화능을 흡광도 값을 비교하였고 상기 흡광도 측정 결과는 도 2에 정리하였다.In the present invention, the antioxidant effect on the components of the overtransferrin extracted from egg whites and the overtransferin hydrolyzate of the present invention was compared with the absorbance value of the control and antioxidant activity in the oil emulsion, and the absorbance measurement results are summarized in FIG.
도 2에 나타난 바와 같이 시료대신 증류수를 첨가한 대조구에 비하여 본 발명 오버트랜스페린 가수분해물은 낮은 TBA값을 나타내었다. 반응 24시간의 경우 대조군의 경우 흡광도 값이 0.419로 나타났으며, 오버트랜스페린(2 mg/mL)의 경우 0.315로 붉은색을 나타내었다. 반면, 본 발명 오버트랜스페린 가수분해물의 경우 1, 2 mg/mL의 농도에서 각각 0.024, 0.039로 낮은 흡광도를 관찰하였다. 상기 결과는 높은 지방 산패 억제능을 의미한다.As shown in FIG. 2, the overtransferin hydrolyzate of the present invention exhibited a low TBA value as compared to the control to which distilled water was added instead of the sample. In the case of the reaction for 24 hours, the absorbance value was 0.419 for the control group and 0.315 for the overtransferin (2 mg / mL). On the other hand, in the case of the overtransferin hydrolyzate of the present invention, low absorbance was observed at 0.024 and 0.039 at concentrations of 1 and 2 mg / mL, respectively. The results indicate high fat rancidence inhibitory activity.
반응 48시간까지 대조군과 오버트랜스페린의 경우 유지 산패가 계속적으로 일어나 최종 0.600 이상의 흡광도 값을 나타내었지만 도 2에 나타난 것처럼 흡광도의 변화가 그리 크지 않았다. 본 발명 오버트랜스페린 가수분해물의 경우 1, 2 mg/mL 농도에서 0.3 정도의 흡광도 값을 나타내었으며, 이는 본 발명 오버트랜스페린의 가수분해물에 의한 약 46~48%의 지방 산패 억제 효과를 나타냈다.
In the control and overtransferin up to 48 hours of reaction, the maintenance rancidation continued to show a final absorbance value of 0.600 or more, but the change in absorbance was not so large as shown in FIG. In the case of the overtransferin hydrolyzate of the present invention, the absorbance value was about 0.3 at the concentration of 1 and 2 mg / mL.
실험예Experimental Example 2 2 FerricFerric thiocyanatethiocyanate ( ( FTCFTC ) 방법에 의한 본 발명 The present invention by the method 오버트랜스페린Overtransferrin 가수분해물 Hydrolyzate 에on 의한 지질과산화 억제 활성 측정 Measurement of lipid peroxidation inhibitory activity
Ferric thiocyanate에 의한 지질과산화 측정은 Kim 등(2004)의 방법을 수정하여 측정하였다. 농도 별 TCEP 이용 가수분해물 0.1 mL에 40 mM phosphate buffer (pH 7.0) 0.4 mL, linoleic acid 0.2 mL(25 mg/mL in ethanol), 증류수 0.2 mL을 혼합하여 stock solution을 만든 후 이를 37°C에서 배양하면서 24시간 마다 흡광도를 측정하였다. 먼저 stock solution 0.1 mL에 70% ethanol 4 mL, 20 mM ferrous chloride, 30% ammonium thiocyanate 0.1 mL씩을 가하여 3분간 반응 후 500 nm에서 흡광도를 측정하였다.
Lipid peroxidation by ferric thiocyanate was measured by modifying Kim et al. (2004). 0.4 mL of 40 mM phosphate buffer (pH 7.0), 0.2 mL of linoleic acid (25 mg / mL in ethanol), and 0.2 mL of distilled water were mixed with 0.1 mL of TCEP-using hydrolyzate by concentration, and then incubated at 37 ° C. Absorbance was measured every 24 hours. First, 4 mL of 70% ethanol, 0.1 mM of 20 mM ferrous chloride, and 30% ammonium thiocyanate were added to 0.1 mL of the stock solution, and the absorbance was measured at 500 nm after reaction for 3 minutes.
Ferric thiocyanate (FTC)법은 지질 산화 초기에 생성되는 과산화물의 양을 측정하여 산화의 정도를 측정하는 것으로(Haraguchi et al., 1992), 형성된 과산화물은 ferrous chloride와 반응하여 붉은색의 ferric chloride 색소를 생성한다(Jeong et al., 2007). 본 발명에서는 비교구로 사용 중인 오버트랜스페린 및 TCEP 이용 가수분해물의 농도를 0.5, 1, 그리고 2 mg/mL로 하여 linoleic acid와 반응시킨 후 24시간 간격으로 흡광도를 측정하여 과산화물 생성량을 조사하여 도 3에 나타냈다. 시료를 첨가하지 않고 용매인 증류수만으로 측정한 대조구(control)의 경우 반응 5일째에 지질 산화에 의한 과산화물의 생성으로 흡광도가 0.825로 높게 측정되었으나, 오버트랜스페린(2 mg/mL)의 경우 0.608, 본 발명 오버트랜스페린의 가수분해물 처리에 의한 흡광도의 경우에는 각각 0.130, 0.164, 0.161로 낮은 수준의 지질 산화가 진행되었음을 알 수 있었다. 반응 5일째에 측정된 대조구의 흡광도 값을 기준으로 하여 각각 처리구의 지질 산화 억제율을 산출한 결과, 오버트랜스페린은 26%로 낮은 산화 억제율을 보였지만 본 발명 오버트랜스페린의 가수분해물의 경우 80% 이상의 산화 억제율을 보였다.
Ferric thiocyanate (FTC) method is used to measure the degree of oxidation by measuring the amount of peroxide produced at the beginning of lipid oxidation (Haraguchi et al., 1992). The formed peroxide reacts with ferrous chloride to produce a red ferric chloride pigment. (Jeong et al., 2007). In the present invention, the concentrations of the overtransferin and TCEP hydrolyzate used as the control were 0.5, 1, and 2 mg / mL and reacted with linoleic acid to measure absorbance at 24 hour intervals to investigate peroxide production in FIG. 3. Indicated. In the case of the control measured only with distilled water as a solvent without adding a sample, the absorbance was measured to be 0.825 due to the formation of peroxide by lipid oxidation on the 5th day of the reaction, but 0.608 for the overtransferin (2 mg / mL) In the case of absorbance by the hydrolyzate treatment of the invention overtransferin it was found that the low level of lipid oxidation progressed to 0.130, 0.164, 0.161, respectively. As a result of calculating the lipid oxidation inhibition rate of each treatment based on the absorbance values of the control group measured on the 5th day of the reaction, the overtransferin showed a low oxidation inhibition rate of 26%, but in the case of the hydrolyzate of the overtransferin of the present invention, the inhibition rate of 80% or more. Showed.
이상에서 설명한 바와 같이, 본 발명은 오버트랜스페린의 가수분해물을 천연 항산화제로 제공하는 효과가 있을 뿐 아니라 양계산업 및 식품산업에 매우 유용한 발명이다.As described above, the present invention not only has the effect of providing the hydrolyzate of overtransferin as a natural antioxidant, but also is very useful for poultry and food industries.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120039672A KR20130117033A (en) | 2012-04-17 | 2012-04-17 | Ovotrasferrin hydrolysate having with antioxidant activity and method for preparation thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120039672A KR20130117033A (en) | 2012-04-17 | 2012-04-17 | Ovotrasferrin hydrolysate having with antioxidant activity and method for preparation thereof |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020150010809A Division KR101631657B1 (en) | 2015-01-22 | 2015-01-22 | Ovotrasferrin hydrolysate having with antioxidant activity and method for preparation thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20130117033A true KR20130117033A (en) | 2013-10-25 |
Family
ID=49635880
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020120039672A KR20130117033A (en) | 2012-04-17 | 2012-04-17 | Ovotrasferrin hydrolysate having with antioxidant activity and method for preparation thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20130117033A (en) |
-
2012
- 2012-04-17 KR KR1020120039672A patent/KR20130117033A/en active Application Filing
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7780873B2 (en) | Bioactive complexes compositions and methods of use thereof | |
KR101729913B1 (en) | Preparation method for broccoli with an increased sulforaphane content and the use of it | |
Nagai et al. | Preparation and functional properties of extracts from bee bread | |
KR101771176B1 (en) | Drink composition | |
CN102469828A (en) | Omega-3 fatty acid enriched beverages | |
JP2008148588A (en) | Polyphenol composition | |
TW201438755A (en) | Aqueous liquid composition containing collagen peptides | |
JP2010222287A (en) | Liquid composition for oral administration | |
JP2001200250A (en) | Antioxidant | |
Pereira et al. | Passion fruit (Passiflora spp.) pulp: A review on bioactive properties, health benefits and technological potential | |
Nagai et al. | Antioxidative ability in a linoleic acid oxidation system and scavenging abilities against active oxygen species of enzymatic hydrolysates from pollen Cistus ladaniferus | |
TWI430754B (en) | Process for producing γ-aminobutyric acid-rich material | |
Ghosh et al. | Nature’s palette: An emerging frontier for coloring dairy products | |
JP2007097465A (en) | Peptide-containing food and drink reduced in bitter taste and astringency, and method for producing the same | |
JP2006014730A (en) | Food product | |
KR20160040096A (en) | Food and drink | |
JP6552097B2 (en) | Bitterness improving agent for food and drink, method for improving bitterness for food and drink, and composition for food and drink | |
KR101631657B1 (en) | Ovotrasferrin hydrolysate having with antioxidant activity and method for preparation thereof | |
Dandge et al. | Evaluation of medicinal and nutritional components from the Eleagnus conferta fruit | |
JP5923896B2 (en) | Galate-type catechin-containing food composition | |
KR20130117033A (en) | Ovotrasferrin hydrolysate having with antioxidant activity and method for preparation thereof | |
KR20180115103A (en) | Method of manufacturing spirulina having increased selenium and use thereof | |
KR100510253B1 (en) | Functional Food Composition having Anti-oxidative, Anti-arthritic and Anti-dementia Activity | |
JP6841444B2 (en) | Immunostimulant | |
JP2012006905A (en) | Composition for skin care |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
A107 | Divisional application of patent | ||
J201 | Request for trial against refusal decision |